Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 August 2009, doi:10.1136/bmj.b3002
Cite this as: BMJ 2009;339:b3002
R Freynhagen, associate professor1, M I Bennett, professor2
1 Department of Anaesthesiology, Critical Care Medicine, Pain Therapy & Palliative Care, Pain Center Lake Starnberg, Benedictus Krankenhaus Tutzing, 82327 Tutzing, Germany, 2 International Observatory on End of Life Care, School of Health and Medicine, Lancaster University, Lancaster LA1 4YT
Correspondence to: R Freynhagen r.freynhagen@krankenhaus-tutzing.de
| The first 150 words of the full text of this article appear below. |
|
Neuropathic pain arises from damage, or pathological change, in the peripheral or central nervous system. It is usually a chronic condition that can be difficult to treat because standard treatment with conventional analgesics does not typically provide effective relief of pain. Patients with neuropathic pain commonly present to primary care professionals, but making a diagnosis may be difficult. Neuropathic pain is usually associated with substantially greater impairment of quality of life compared with other types of chronic pain, and
Tricyclic antidepressants (amitriptyline, nortriptyline, desipramine)
2-
anticonvulsants (gabapentin and pregabalin)
Serotonin and norepinephrine reuptake inhibitors (duloxetine, venlafaxine)
Topical 5% lidocaine patch
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses